Analysts on Wall Street project that Baxter International (BAX) will announce quarterly earnings of $0.66 per share in its forthcoming report, representing an increase of 20% year over year. Revenues are projected to reach $3.74 billion, increasing 1% from the same quarter last year.Over the last 30 days, there has been a downward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial for ...

Baxter International Inc. (BAX) announced the launch of its Helion Integrated Surgical System in Thailand. This innovative system leverages advanced operating room integration (ORI) to simplify the complexities of surgical environments. By enhancing OR efficiency and enabling surgical teams to stay focused and connected, the Helion system represents a significant advancement in medical technology.The Helion Integrated Surgical System was launched by Hillrom in the U.S. market in 2021. Besides Thailand, the ...

ipopba Healthcare remains one of my favorite sectors to find names that offer growth and income due to the inelastic demand for products and services. The steady nature of many companies in this sector paves the way for a return of capital through share repurchases and dividends. It is the latter of these capital returns that really has my attention when it comes to investing. Baxter International (NYSE:BAX) is a name I have followed in the past, but have never purchased, primarily because the valuation ...

Shares of Baxter International Inc (NYSE:BAX) are down 2.9% at $34.28, after a downgrade from Morgan Stanley to "underweight" from "equal weight," with a price-target cut to $30 from $39. The firm raised concerns over the medical equipment name's margin goals, noting its financial outlook may be more challenging than previously thought, particularly after its acquisition of Hillrom. On the charts, support at the $33 level kept losses in check over the past couple months. However, overhead pressure at the 60 ...

Shares of Baxter International (BAX) have gained 2.4% in the first seven trading sessions in July after declining 13.5% in the first six months of 2024.The decline in BAX’s shares during the first half can be attributed to challenges, including inflationary pressure and weaker ESRD patient volume in China due to the residual impact of COVID-19. Moreover, China’s value-based procurement initiatives are lowering realized price for the company’s products in the country.Meanwhile, the recovery in Baxter’s share ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true v ...

Shares of Baxter International (BAX) have gained 2.8% since Jun 26, after the company announced the recall of its Life2000 Ventilation System. Though the share price had declined following the news, it recovered following reports of potential discussion on divestment of BAX’s kidney care segment.The device, a portable ventilator for patients suffering from chronic respiratory failure or other breathing issues, has been recalled by Baxter. The recall follows the detection of damaged battery charger dongles, ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.W ...

Baxter International (BAX) is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 12.4% year to date against the industry's 3.1% growth. The S&P 500 Index has increased 11.6% in the same time frame.BAX, with a market capitalization of $17.27 billion, is a global medical technology company providing items such as kidney-dialysis equipment, infusio ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores.What are t ...